SE408302B - Forfarande for framstellning av 1,4-bensodiazepin-derivat - Google Patents

Forfarande for framstellning av 1,4-bensodiazepin-derivat

Info

Publication number
SE408302B
SE408302B SE7311319A SE7311319A SE408302B SE 408302 B SE408302 B SE 408302B SE 7311319 A SE7311319 A SE 7311319A SE 7311319 A SE7311319 A SE 7311319A SE 408302 B SE408302 B SE 408302B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
benzodiazepin
derivatives
benzodiazepin derivatives
Prior art date
Application number
SE7311319A
Other languages
English (en)
Inventor
G O Chase
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE408302B publication Critical patent/SE408302B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/30Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7311319A 1972-08-21 1973-08-20 Forfarande for framstellning av 1,4-bensodiazepin-derivat SE408302B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28221772A 1972-08-21 1972-08-21
US35981473A 1973-05-14 1973-05-14

Publications (1)

Publication Number Publication Date
SE408302B true SE408302B (sv) 1979-06-05

Family

ID=26961312

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7311319A SE408302B (sv) 1972-08-21 1973-08-20 Forfarande for framstellning av 1,4-bensodiazepin-derivat

Country Status (24)

Country Link
JP (1) JPS5911589B2 (sv)
AR (1) AR198108A1 (sv)
AT (1) AT341527B (sv)
AU (1) AU472777B2 (sv)
CA (1) CA1012535A (sv)
CH (1) CH578544A5 (sv)
DD (1) DD107040A5 (sv)
DE (1) DE2340159A1 (sv)
DK (1) DK155326C (sv)
ES (1) ES418014A1 (sv)
FI (1) FI57939C (sv)
FR (1) FR2197003B1 (sv)
GB (1) GB1392681A (sv)
HU (1) HU170153B (sv)
IE (1) IE38091B1 (sv)
IL (1) IL42947A (sv)
LU (1) LU68269A1 (sv)
NL (1) NL179582C (sv)
NO (1) NO139481C (sv)
PH (1) PH13640A (sv)
PL (1) PL99162B1 (sv)
SE (1) SE408302B (sv)
SU (1) SU550980A3 (sv)
YU (1) YU219873A (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5334792A (en) * 1976-09-13 1978-03-31 Scherico Ltd Production of 1*44 benzodiazepines and 1*44 benzodiazepinee22ones
CN113149915B (zh) * 2021-03-01 2024-03-15 中国科学院成都有机化学有限公司 一种合成氯硝西泮化合物的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1136709B (de) * 1959-12-10 1962-09-20 Hoffmann La Roche Verfahren zur Herstellung von 2-Oxo-1, 2-dihydro-1, 4-benzodiazepinen
CH537393A (de) * 1969-10-16 1973-05-31 Hoffmann La Roche Verfahren zur Herstellung von 1,4-Benzodiazepin-derivaten
BE785962A (fr) * 1971-07-08 1973-01-08 Hoffmann La Roche Procede pour la preparation de derives de benzodiazepine

Also Published As

Publication number Publication date
NL179582C (nl) 1986-10-01
AU472777B2 (en) 1976-06-03
SU550980A3 (ru) 1977-03-15
DK155326C (da) 1989-08-14
AU5918073A (en) 1975-02-13
NO139481C (no) 1979-03-21
DE2340159C2 (sv) 1989-01-19
DD107040A5 (sv) 1974-07-12
IL42947A0 (en) 1973-11-28
YU219873A (en) 1982-06-30
JPS4956992A (sv) 1974-06-03
FI57939B (fi) 1980-07-31
CA1012535A (en) 1977-06-21
JPS5911589B2 (ja) 1984-03-16
LU68269A1 (sv) 1975-05-21
NL7311507A (sv) 1974-02-25
FI57939C (fi) 1980-11-10
HU170153B (sv) 1977-04-28
ATA720773A (de) 1977-06-15
AR198108A1 (es) 1974-05-31
CH578544A5 (sv) 1976-08-13
DE2340159A1 (de) 1974-03-07
AT341527B (de) 1978-02-10
IE38091B1 (en) 1977-12-21
ES418014A1 (es) 1976-03-16
PL99162B1 (pl) 1978-06-30
NL179582B (nl) 1986-05-01
FR2197003B1 (sv) 1978-01-13
IE38091L (en) 1974-02-21
IL42947A (en) 1977-01-31
NO139481B (no) 1978-12-11
DK155326B (da) 1989-03-28
GB1392681A (en) 1975-04-30
PH13640A (en) 1980-08-18
FR2197003A1 (sv) 1974-03-22

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
SE390819B (sv) Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE381047B (sv) Forfarande for framstellning av 3-substituerade 1,2-bensisoxazolderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE396385B (sv) Forfarande for framstellning av n-benshydryl-n'-p-hydroxibensyl-piperaziner
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE416201B (sv) Foerfarande foer framstaellning av 1,4-bensodiazepinderivat
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
AR200162A1 (es) Procedimiento para la preparacion de derivados 1,2,4-triazolicos
SE381046B (sv) Forfarande for framstellning av 1,4-bensodiazepinderivat
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
SE408302B (sv) Forfarande for framstellning av 1,4-bensodiazepin-derivat
NO137725C (no) Fremgangsmaate for selektiv fremstilling av 1,2-dikloretan
SE399254B (sv) Forfarande for framstellning av kinazolinonderivat
SE386673B (sv) Forfarande for framstellning av 2-amino-2-oxazoliner